Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis Council
Arnon D. Cohen, Ronald Vender, Luigi Naldi, et al.
JAAD International (2020) Vol. 1, Iss. 2, pp. 224-230
Open Access | Times Cited: 10

Showing 10 citing articles:

Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study
Mark Lebwohl, John Koo, Janusz Jaworski, et al.
Advances in Therapy (2025)
Open Access | Times Cited: 2
A Randomized, Double-blind, Phase III Study Assessing Clinical Similarity of SB17 (Proposed Ustekinumab Biosimilar) to Reference Ustekinumab in Subjects with Moderate to Severe Plaque Psoriasis
Steven R. Feldman, Joanna Narbutt, Giampiero Girolomoni, et al.
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 3, pp. 440-447
Closed Access | Times Cited: 8
Biosimilars for Australian Dermatologists
Grace X. Li, Mona Marabani, Deshan F. Sebaratnam
Australasian Journal of Dermatology (2025)
Open Access
Real‐world experience of multiple switches between adalimumab biosimilars in patients with psoriasis
Ole Krogh‐Jensen, C. Schwarz, Diljit Kaur‐Knudsen, et al.
Journal of the European Academy of Dermatology and Venereology (2025)
Closed Access
Genital Psoriasis: Shining Light on This Hidden Disease
Jennifer Clay Cather, Melodie Young, Muriel Boreham, et al.
JEADV Clinical Practice (2025)
Open Access
Belgian recommendations for managing psoriasis in a changing treatment landscape
Reinhart Speeckaert, Arjen Nikkels, Jo Lambert, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Closed Access | Times Cited: 2
A review of biosimilars in psoriasis: impacts on efficacy, safety, access, and a first-hand look at biosimilar cost savings within the department of veterans affairs
Rebecca R Reese, Shiva Ram Nanavath, Jennifer L. Martin, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 1
The importance of illness severity and multimorbidity in the association between mental health and body weight in psoriasis: Cross‐sectional and longitudinal analysis
Neli T. Pavlova, Rona Moss‐Morris, Catherine Smith, et al.
Skin Health and Disease (2022) Vol. 2, Iss. 4
Open Access | Times Cited: 4
Cost-Effectiveness Analysis of Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis from a Health Care Provider's Perspective
Jerzy Duda
Bioequivalence & Bioavailability International Journal (2023) Vol. 7, Iss. 2, pp. 1-19
Open Access
Cost-effectiveness analysis of biological drugs in treating moderate to severe plaque psoriasis from the perspective of a health service provider
Jaroslav Duda
Klinická farmakologie a farmacie (2022) Vol. 36, Iss. 2, pp. 54-67
Open Access
‘I don't know which is the chicken and which is the egg’: A qualitative study of weight loss‐related beliefs and behaviours among adults with psoriasis and comorbid obesity
Neli T. Pavlova, Celeny Ramasawmy, Federica Picariello, et al.
British Journal of Health Psychology (2022) Vol. 28, Iss. 2, pp. 532-551
Open Access
Page 1

Scroll to top